Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...

HIMS expands its tech-driven care with new diagnostics, hormonal treatments, and a Canada launch via Livewell.

If you are wondering whether Hims & Hers Health is still a smart buy after its big run, you are not alone. This stock has quickly moved from a niche telehealth play to one of the market's more talked ...

Delving into the details, we found 53% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $373,316, and 7 were calls, valued ...

Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

Hims & Hers Health ($HIMS) is strengthening its position in the UK with the launch of weight-loss programs. This launch will ...

The move into the UK weight-loss category has been facilitated by the acquisition earlier this year of Zava, a London-based ...

Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers.

Hims Hers Health Inc (NYSE:HIMS) stock fell 4.4% Wednesday after U.S. lawmakers introduced legislation that could ...

Online telehealth company Hims and Hers Health HIMS.N is launching its weight-loss membership and treatment plans in the UK ...

The market is projected to reach $110.61 billion by 2030, growing at a 38.6% clip from 2025, as ROI-focused tools displace experimental pilots ( [3]) . With nearly 40% of hospitals now operating at ...

Online telehealth company Hims and Hers Health is launching weight-loss membership and treatment plans in the UK. The new service will offer drugs such as Novo Nordisk's Wegovy and Eli Lilly's ...